MedPath
HSA Approval

AXCEL KAOPEC SUSPENSION

SIN06496P

AXCEL KAOPEC SUSPENSION

AXCEL KAOPEC SUSPENSION

August 19, 1991

KOTRA PHARMA MARKETING

KOTRA PHARMA MARKETING

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantKOTRA PHARMA MARKETING
Licence HolderKOTRA PHARMA MARKETING

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

A07BC30

combinations

Manufacturer Information

KOTRA PHARMA MARKETING

KOTRA PHARMA (M) SDN BHD

Active Ingredients

PECTIN

5 mg/5 ml

Pectin

KAOLIN LIGHT

1 g/5 ml

Kaolin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AXCEL KAOPEC SUSPENSION - HSA Approval | MedPath